Prospectus Supplement dated November 6, 2002 (To Prospectus filed on January 10, 2002) |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-71620 |
Micron Technology, Inc.
29,069,767 Shares
Common Stock
This prospectus supplement relates to the resale by the selling stockholders of 29,069,767 shares of our common stock, $0.10 par value, that are issuable upon the exercise of warrants sold initially by us in private placements in July 2001 and August 2001.
This prospectus supplement should be read in conjunction with the prospectus filed on January 10, 2002, together with any amendments or supplements thereto, which is to be delivered with this prospectus supplement.
The information in the table appearing under the heading "Selling Stockholders" commencing on page 12 of the prospectus is hereby amended by adding the information below with respect to persons not previously listed in the prospectus or in any amendments or supplements thereto, and by superceding the information with respect to persons previously listed in the prospectus or in any amendments or supplements thereto that are listed below:
|
Number of Shares Beneficially Owned Prior to the Offering(1) |
|
Number of Shares Beneficially Owned After the Offering(3) |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Name |
Number of Shares That May Be Sold in the Offering(2) |
|||||||||
Number |
Percentage |
Number |
Percentage |
|||||||
TQA Master Fund, Ltd. | 175,000 | * | 175,000 | 0 | * | |||||
TQA Master Plus Fund, Ltd. | 175,000 | * | 175,000 | 0 | * | |||||
Wachovia Securities Inc. | 678,454 | * | 678,454 | 0 | * |
Information concerning the selling stockholders is based upon information provided to us by the stockholders. This information may change from time to time and any changed information of which we are apprised will be set forth in future prospectus supplements if and when necessary.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.